MIR7-3HG
gene geneOn this page
Also known as PGSF1PGSF1aPGSF1bHuh7uc002mbe.2
Summary
MIR7-3HG (MIR7-3 host gene, HGNC:30049) is a long non-coding RNA gene on chromosome 19p13.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30049 |
| Approved symbol | MIR7-3HG |
| Name | MIR7-3 host gene |
| Location | 19p13.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2 |
| Ensembl gene | ENSG00000176840 |
| Ensembl biotype | lncRNA |
| Entrez | 284424 |
| RNAcentral | URS000075D132 — lncRNA, 768 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 84 — 84 lncRNA
ENST00000317292, ENST00000586721, ENST00000588711, ENST00000588758, ENST00000588923, ENST00000589368, ENST00000589639, ENST00000591008, ENST00000592663, ENST00000592709, ENST00000653012, ENST00000653316, ENST00000653355, ENST00000653646, ENST00000654084, ENST00000654534, ENST00000655163, ENST00000655375, ENST00000655494, ENST00000656089, ENST00000656469, ENST00000657100, ENST00000657474, ENST00000658545, ENST00000658818, ENST00000660172, ENST00000660889, ENST00000660973, ENST00000661584, ENST00000662608, ENST00000662725, ENST00000663010, ENST00000663176, ENST00000663804, ENST00000664951, ENST00000665092, ENST00000666056, ENST00000666837, ENST00000666978, ENST00000667215, ENST00000667223, ENST00000667444, ENST00000668602, ENST00000669248, ENST00000669408, ENST00000669700, ENST00000669889, ENST00000670131, ENST00000670508, ENST00000684819, ENST00000688490, ENST00000691766, ENST00000702540, ENST00000702630, ENST00000702698, ENST00000702816, ENST00000767162, ENST00000767163, ENST00000767164, ENST00000767165, ENST00000767166, ENST00000767167, ENST00000767168, ENST00000767169, ENST00000767170, ENST00000767171, ENST00000767172, ENST00000767173, ENST00000767174, ENST00000767175, ENST00000767176, ENST00000767177, ENST00000767178, ENST00000767179, ENST00000767180, ENST00000767181, ENST00000767182, ENST00000767183, ENST00000767184, ENST00000767185, ENST00000767186, ENST00000767187, ENST00000767188, ENST00000767189
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000317292 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003571843 | 4769630 | 4769757 |
| ENSE00004126455 | 4772164 | 4772588 |
| ENSE00004126479 | 4769127 | 4769351 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 99.43.
FANTOM5 (CAGE): breadth broad, TPM avg 11.1334 / max 3953.1063, expressed in 243 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173370 | 11.1334 | 243 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pituitary gland | UBERON:0000007 | 99.43 | gold quality |
| adenohypophysis | UBERON:0002196 | 99.13 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.25 | gold quality |
| sperm | CL:0000019 | 89.29 | silver quality |
| right frontal lobe | UBERON:0002810 | 88.27 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 88.21 | gold quality |
| hypothalamus | UBERON:0001898 | 86.75 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 86.71 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.64 | gold quality |
| Ammon’s horn | UBERON:0001954 | 85.63 | gold quality |
| prefrontal cortex | UBERON:0000451 | 85.25 | gold quality |
| amygdala | UBERON:0001876 | 85.03 | gold quality |
| pancreas | UBERON:0001264 | 84.71 | gold quality |
| neocortex | UBERON:0001950 | 84.35 | gold quality |
| frontal cortex | UBERON:0001870 | 84.26 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 84.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 83.89 | gold quality |
| cerebellar cortex | UBERON:0002129 | 83.78 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 83.68 | gold quality |
| cerebral cortex | UBERON:0000956 | 83.63 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.39 | gold quality |
| forebrain | UBERON:0001890 | 82.34 | gold quality |
| cerebellum | UBERON:0002037 | 82.13 | gold quality |
| brain | UBERON:0000955 | 80.88 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.75 | silver quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 80.56 | gold quality |
| body of pancreas | UBERON:0001150 | 80.40 | gold quality |
| right testis | UBERON:0004534 | 80.28 | gold quality |
| primary visual cortex | UBERON:0002436 | 80.22 | gold quality |
| left testis | UBERON:0004533 | 80.20 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- These findings point to a new mechanism by which miR-7 exerts cytoprotective effects by regulating the Nrf2 pathway. (PMID:26453926)
- Our study suggested that miR-7 suppressed the expression of VDAC1 in hepatocellular carcinoma (PMID:26831666)
- miR-7-KLF4-VEGF signaling axis plays an important role in the regulation of angiogenesis in human umbilical vein endothelial cells , suggesting that miR-7 is a potential agent for the development of anti-angiogenic therapeutics in vascular diseases and solid tumors (PMID:27431648)
- These data suggest a new and interesting role of MIR7-3HG as an anti-autophagic MIRNA that may affect oncogenesis through the regulation of the tumor suppressor AMBRA1. (PMID:28059583)
- A peptide encoded by lncRNA MIR7-3 host gene (MIR7-3HG) alleviates dexamethasone-induced dysfunction in pancreatic beta-cells through the PI3K/AKT signaling pathway. (PMID:36731335)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.